Good News! The Diabetes Technology Society (DTS) has announced the launch of the DTS Surveillance Program for Cleared Blood Glucose Monitors. This surveillance program will provide independent assessment of the performance of cleared blood glucose monitors following Food and Drug Administration (FDA) clearance against accepted standards, and generate information that can assist patients, healthcare providers,

Read more…

The diabetes community needs champions like the Diabetes Technology Society, who held an important meeting in Bethesda, Maryland on September 9, 2013 titled: “Verifying the Performance of Blood Glucose Monitors Following FDA Clearance”. THE IMPORTANT TAKEAWAY: The DTS has announced they will develop an independent post-market surveillance testing program to ensure that blood glucose monitors and

Read more…

The following link will take you to  letter from the FDA to diabetes device company. It would appear that medical device reports should have been filed when meter failed to report lows. Here is a little quote that makes it clear why we need to StripSafely: Complaints 618, 779, 728, and 818 describe events in which

Read more…

Dr. Richard Kahn professor of medicine at the University of North Carolina and  formerly chief scientific and medical officer of the American Diabetes Association wrote a commentary in Roll Call titled: Competitive Bidding Puts Diabetes Patients at Risk. In that piece he says: Many of our most vulnerable citizens will assume the test they use is

Read more…